Registered Zambia · ZAMRA

Oxyvet Plus L.A 100ml

Ketoprofen 30 mg,Magnesium Oxide 20 mg,Oxytetracycline 200 mg

ZAMRA-VM-26-217 Injection 20 mg,200 mg,30 mg musculo-skeletal system INN generic

What it does

Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and reduce inflammation.

Commonly used for: pain relief (analgesia), inflammation reduction, arthritis (rheumatoid arthritis, osteoarthritis), muscle pain …

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
ZAMRA-VM-26-217
Registration date
2026-06-15
Expiry date
2031-06-14
Status
Registered/Compliant
Active ingredient
Ketoprofen 30 mg,Magnesium Oxide 20 mg,Oxytetracycline 200 mg
Dosage form
Injection
Strength
20 mg,200 mg,30 mg
Pack size
-
Therapeutic class
-
ATC class (WHO)
M01AE - Propionic acid derivatives
RxNorm RxCUI
6142
Country of origin
China
Manufacturer location
189 Tai Hang Nan Da Jie, Yu Hua Qu, Shi Jia Zhuang Shi, He Bei Sheng, China, 050036

Source: Zambia Medicines Regulatory Authority · fetched 2026-06-28 06:27:42 · updated 2026-09-17 03:40:09

Drug Interactions

22
Check interactions

Pharmacodynamic Warnings

Oxytetracycline appears in TABLE 1: Drugs that cause hepatotoxicity

Ketoprofen appears in TABLE 2: Drugs that cause nephrotoxicity

Ketoprofen appears in TABLE 4: Drugs with antiplatelet effects

Ketoprofen appears in TABLE 16: Drugs that increase serum potassium

Ketoprofen appears in TABLE 18: Drugs that cause hyponatraemia

Severe (2)

Mifamurtide - decreases efficacy

NSAIDs(high-dose)arepredictedtodecreasetheefficacyof mifamurtide.Avoid.rTheoretical

Severe Theoretical

Tetracyclines - decreases absorption

Strontium is predicted to decrease the absorption of tetracyclines. Avoid. Theoretical Sucralfate

Severe Theoretical

Moderate (8)

Antiarrhythmics - increases exposure

NSAIDs (celecoxib) are predicted to increase the exposure to antiarrhythmics (flecainide, propafenone). Monitor and adjust dose.

Moderate Theoretical

Cladribine - increases exposure

NSAIDs(sulindac)mightincreasetheexposuretocladribine. Avoidoradjustdose.oTheoretical

Moderate Theoretical

Flecainide - increases exposure

NSAIDs (celecoxib) are predicted to increase the exposure to antiarrhythmics (flecainide, propafenone). Monitor and adjust dose.

Moderate Theoretical

Lithium - increases risk of lithium toxicity

Tetracyclines are predicted to increase the risk of lithium toxicity when given with lithium. Avoid or adjust dose.

Moderate Anecdotal

Pemetrexed - increases exposure

NSAIDs are predicted to increase the exposure to pemetrexed. Use with caution or avoid. Also see TABLE 2 p. 1517

Moderate Theoretical

Propafenone - increases exposure

NSAIDs (celecoxib) are predicted to increase the exposure to antiarrhythmics (flecainide, propafenone). Monitor and adjust dose.

Moderate Theoretical

Tetracyclines - decreases concentration

Fosphenytoin is predicted to decrease the concentration of tetracyclines (doxycycline). Adjust dose.

Moderate Theoretical

Tetracyclines - decreases exposure

Rifampicin modestly decreases the exposure to tetracyclines (doxycycline). Adjust dose.

Moderate Study

Unknown (12)

Alendronate - increases risk of gastrointestinal irritation

NSAIDs are predicted to increase the risk of gastrointestinal irritation when given with bisphosphonates (alendronate, ibandronate).

Unknown Study

Bisphosphonates - increases risk of gastrointestinal irritation

NSAIDs are predicted to increase the risk of gastrointestinal irritation when given with bisphosphonates (alendronate, ibandronate).

Unknown Study

Bisphosphonates - increases risk of renal impairment

NSAIDs are predicted to increase the risk of renal impairment when given with bisphosphonates (clodronate).

Unknown Study

Clodronate - increases risk of renal impairment

NSAIDs are predicted to increase the risk of renal impairment when given with clodronate.

Unknown Study

Deferasirox - increases risk of gastrointestinal bleeding

NSAIDs are predicted to increase the risk of gastrointestinal bleeding when given with deferasirox.

Unknown Theoretical

Data from BNF 85 (British National Formulary). This is not a substitute for professional medical advice. Matched via: class

Disclaimer: This information is sourced from Zambia Medicines Regulatory Authority (Zambia). Always consult a qualified healthcare professional before using any medication.

About ketoprofen

Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and reduce inflammation.

What it treats

  • pain relief (analgesia)
  • inflammation reduction
  • arthritis (rheumatoid arthritis, osteoarthritis)
  • muscle pain
  • menstrual pain
  • gout

How it works

Ketoprofen works by blocking certain chemicals in the body that cause pain and inflammation.

Who it's for

Ketoprofen is for adults who need relief from pain or inflammation.

Drug class

NSAIDs

Cautions

  • • Avoid using with other drugs that can harm the kidneys.
  • • Be cautious if taking medications that affect blood clotting.
  • • Use with care if on medicines that can raise potassium levels.
  • • Monitor if using drugs that can lower sodium levels.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About oxide

Oxide is a type of compound often used in various treatments. It is important to understand its uses and any precautions necessary when taking it.

What it treats

  • treatment of certain skin conditions
  • used in some respiratory therapies

How it works

Oxide works by interacting with the body in a way that helps improve certain health conditions.

Who it's for

Oxide may be suitable for individuals suffering from specific health issues as determined by their healthcare provider.

Cautions

  • • Always follow the healthcare provider's instructions when using this compound.
  • • Inform your doctor about any other medications you are taking.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About oxytetracycline

Oxytetracycline is an antibiotic used to treat various bacterial infections.

What it treats

  • bacterial infections
  • acne
  • respiratory infections
  • urinary tract infections

How it works

It works by stopping the growth of bacteria, helping to eliminate the infection.

Who it's for

It is for adults and children over the age of 12 who have specific bacterial infections.

Drug class

Tetracyclines

Cautions

  • • Avoid use with other medications that can harm the liver.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: Oxytetracycline

BNF-referenced

Oxytetracycline is a broad-spectrum antibiotic belonging to the tetracycline class. It is effective against a variety of bacterial infections, including those caused by Chlamydia, Rickettsia, and Mycoplasma. This medication works by inhibiting protein synthesis in bacteria, making it a vital option in treating susceptible infections. Its use is cautioned in pediatric populations due to potential adverse effects on bone and dental development.

Indications

  • Bacterial infections (e.g. Chlamydia, Rickettsia, Mycoplasma)
  • Acne
  • Prophylaxis of asymptomatic meningococcal carrier state (not recommended)

Dosage

Adults: For adult patients, the typical dosage of oxytetracycline for susceptible infections is 100 mg twice daily for 5 days. For other conditions, such as acne, the dosage may be 500 mg twice daily, usually for a duration of 6 to 12 weeks, with the possibility of repeating the course intermittently.

Mechanism of action

Oxytetracycline exerts its antibacterial effects by binding to the 30S ribosomal subunit of bacteria, inhibiting the binding of aminoacyl-tRNA to the mRNA-ribosome complex. This action prevents the synthesis of proteins essential for bacterial growth and replication, leading to the bacteriostatic effect of the drug.

Pharmacodynamics

The pharmacodynamics of oxytetracycline involve its ability to inhibit bacterial protein synthesis, which is critical for the growth and reproduction of bacteria. The drug demonstrates a broad spectrum of activity against both Gram-positive and Gram-negative organisms, as well as some atypical pathogens. Its effectiveness can be influenced by the presence of tetracycline resistance mechanisms in certain bacterial strains.

Pharmacokinetics

Oxytetracycline is well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 1-2 hours after oral administration. It has a relatively long half-life of about 8-10 hours, allowing for twice-daily dosing. The drug is widely distributed in body tissues and fluids, including the liver, kidneys, and lungs, but is less effective in central nervous system infections due to limited penetration. It is primarily excreted via urine, and dosage adjustments may be necessary in patients with renal impairment.

Contra-indications

  • Children under 12 years due to deposition in growing bone and teeth, causing staining and occasionally dental hypoplasia

Adverse effects

  • Gastrointestinal disturbances
  • Photosensitivity
  • Dental discoloration
  • Hepatotoxicity
  • Renal impairment
  • Skin reactions including rash and urticaria
  • Ataxia
  • Hearing impairment
  • Colitis
  • Systemic lupus erythematosus exacerbation

Interactions

  • Antacids and supplements containing calcium, magnesium, or iron may reduce absorption
  • Oral contraceptives may be less effective
  • Other tetracyclines
  • Warfarin (may increase anticoagulant effect)

Precautions

  • Use with caution in patients with renal impairment
  • Monitor for hepatic toxicity in long-term use
  • Patients should be advised to avoid excessive sunlight exposure
  • Discontinue if systemic lupus erythematosus develops or worsens

Pregnancy

Oxytetracycline is contraindicated during pregnancy due to potential harm to fetal development, particularly affecting bone and dental health.

Breast-feeding

Use with caution; oxytetracycline is excreted in breast milk and may affect the infant's dental health.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

  • Oxytetracycline 250 mg tablets
  • Oxytetracycline oral suspension
  • Oxytetracycline oral solution
BNF 85 (British National Formulary) p.646 BNF for Children 2019-2020 p.389 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: Ketoprofen

BNF-referenced

Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that exhibits analgesic, anti-inflammatory, and antipyretic properties. It is commonly used to relieve pain and inflammation associated with musculoskeletal disorders such as rheumatoid arthritis and osteoarthritis, as well as to alleviate moderate pain from various causes. Due to its mechanism of action and pharmacological profile, ketoprofen is effective in managing conditions that involve pain and inflammation.

Indications

  • Pain and inflammation in musculoskeletal disorders
  • Rheumatoid arthritis
  • Osteoarthritis
  • Dysmenorrhea
  • Moderate pain relief

Mechanism of action

Ketoprofen's anti-inflammatory effects are primarily due to the inhibition of cyclooxygenase-2 (COX-2), an enzyme crucial for prostaglandin synthesis in the arachidonic acid pathway. This leads to reduced levels of prostaglandins, which mediate pain, fever, and inflammation. Ketoprofen also inhibits cyclooxygenase-1 (COX-1), contributing to its side effects such as gastrointestinal discomfort and ulceration. Additionally, it exhibits anti-bradykinin activity and stabilizes lysosomal membranes. Its antipyretic effects may involve action on the hypothalamus, enhancing peripheral blood flow, vasodilation, and heat dissipation.

Pharmacodynamics

As a nonsteroidal anti-inflammatory agent (NSAIA), ketoprofen shares pharmacological actions with other typical NSAIDs by inhibiting prostaglandin synthesis. It is effective in treating various conditions, including rheumatoid arthritis, osteoarthritis, and dysmenorrhea, and is used to alleviate moderate pain, thus providing both analgesic and anti-inflammatory effects.

Pharmacokinetics

Ketoprofen is absorbed from the gastrointestinal tract, with peak plasma concentrations typically reached within 1 to 2 hours after oral administration. It is extensively metabolized in the liver, primarily through conjugation, and excreted mainly via the urine. The drug has a half-life of approximately 1.5 to 2 hours, but this may vary based on individual factors such as age and liver function. Caution is advised in patients with hepatic or renal impairment, as these conditions may alter the drug's pharmacokinetics and increase the risk of adverse effects.

Contra-indications

  • History of gastrointestinal perforation or ulceration
  • Severe heart failure
  • History of hypersensitivity to aspirin or other NSAIDs

Adverse effects

  • Gastrointestinal discomfort
  • Nausea
  • Constipation
  • Dizziness
  • Drowsiness
  • Fatigue
  • Headache
  • Rash
  • Paraesthesia
  • Skin reactions
  • Increased risk of infection
  • Angioedema
  • Renal impairment
  • Hypersensitivity reactions
  • Photosensitivity
  • Hematologic disorders
  • Stomatitis
  • Tinnitus
  • Vision disorders
  • Weight increase

Interactions

  • May affect performance of skilled tasks such as driving
  • Other NSAIDs may increase the risk of adverse effects

Precautions

  • Caution in patients with dehydration or renal impairment
  • Use with caution in elderly patients due to increased risk of serious side effects
  • Careful monitoring required for prolonged therapy
  • Caution advised in patients with a history of gastrointestinal disorders

Pregnancy

Avoid unless the potential benefit outweighs the risk. Avoid during the third trimester due to risk of fetal ductus arteriosus closure.

Breast-feeding

Amount probably too small to be harmful, but use with caution and avoid large amounts.

Storage

Store at room temperature, away from moisture and heat.

Formulations

  • Oral suspension
  • Oral solution
  • Suppositories
BNF 85 (British National Formulary) p.1280 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: oxide

BNF-referenced

Oxide refers to a chemical compound that contains at least one oxygen atom and one other element. Oxides can be formed from a variety of elements, and their properties can vary significantly depending on the specific elements involved. Common oxides include metal oxides, such as iron oxide (rust), and non-metal oxides, such as carbon dioxide. In a pharmaceutical context, oxides may play roles as inactive ingredients or act as preservatives or stabilizers in drug formulations.

Mechanism of action

Oxides do not have a single mechanism of action as they are a broad category of compounds. However, in general, metal oxides can exhibit catalytic properties, while non-metal oxides may participate in biochemical reactions by forming acids or bases upon dissolution in water.

Pharmacodynamics

The pharmacodynamics of oxides depend on the specific type of oxide and its interaction with biological systems. For instance, metal oxides may have antimicrobial properties, while certain non-metal oxides can influence metabolic pathways through their acid-base chemistry. The effects vary widely, necessitating specific studies for each oxide's role in therapeutic contexts.

Pharmacokinetics

The pharmacokinetics of oxides are also variable. Many metal oxides are poorly soluble and thus have limited absorption when ingested. Non-metal oxides, such as carbon dioxide, can be readily absorbed and utilized in metabolic processes. The distribution, metabolism, and excretion of oxides depend on their chemical form and the biological system in which they are involved.

Pregnancy

Not applicable as oxide is not a drug but a class of chemical compounds.

Breast-feeding

Not applicable as oxide is not a drug but a class of chemical compounds.

Storage

Store in a cool, dry place away from direct sunlight.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: Ketoprofen

PubChem CID 3825

Molecular formula: C16H14O3

Mechanism of action

The anti-inflammatory effects of ketoprofen are believed to be due to inhibition cylooxygenase-2 (COX-2), an enzyme involved in prostaglandin synthesis via the arachidonic acid pathway. This results in decreased levels of prostaglandins that mediate pain, fever and inflammation. Ketoprofen is a non-specific cyclooxygenase inhibitor and inhibition of COX-1 is thought to confer some of its side effects, such as GI upset and ulceration. Ketoprofen is thought to have anti-bradykinin activity, as well as lysosomal membrane-stabilizing action. Antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation.

Pharmacodynamics

Ketoprofen is a nonsteroidal anti-inflammatory agent (NSAIA) with analgesic and antipyretic properties. Ketoprofen has pharmacologic actions similar to those of other prototypical NSAIDs, which inhibit prostaglandin synthesis. Ketoprofen is used to treat rheumatoid arthritis, osteoarthritis, dysmenorrhea, and alleviate moderate pain.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

Molecular reference: Oxytetracycline

PubChem CID 54675779

Molecular formula: C22H24N2O9

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

Molecular reference: oxide

PubChem CID 190217

Molecular formula: O-2

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.